May 7, 2020 / 11:14 AM / 23 days ago

BRIEF-Tonix Pharmaceuticals Enters Agreement With University Of Alberta To Develop COVID-19 Vaccines

May 7 (Reuters) - Tonix Pharmaceuticals Holding Corp :

* TONIX PHARMACEUTICALS ENTERS INTO RESEARCH COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY OF ALBERTA TO DEVELOP NOVEL HORSEPOX-BASED VACCINES, TNX-1810, TNX-1820 AND TNX-1830, FOR THE PREVENTION OF COVID-19

* TONIX PHARMACEUTICALS - COLLABORATION WILL DEVELOP THREE NEW POTENTIAL VACCINES TO PROTECT AGAINST COVID-19 BASED ON HORSEPOX VECTOR PLATFORM

* TONIX PHARMACEUTICALS - TONIX WILL CONDUCT FURTHER STUDIES TO TEST SAFETY AND EFFICACY OF TNX-1810, TNX-1820 AND TNX-1830 IN PREVENTING COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below